Benchmarking AWaRe: estimating optimal levels of AWaRe antibiotic use in 186 countries, territories and areas based on clinical infection and resistance burden
This study establishes the first standardized, benchmarking-based methodology to estimate optimal national levels of total and AWaRe-classified antibiotic use for 186 countries based on local infection and resistance burdens, revealing that while the global 70% Access target is appropriate, most countries currently overuse Watch antibiotics compared to these evidence-based targets.